Esperion Therapeutics
ESPR
ESPR
182 hedge funds and large institutions have $1.64B invested in Esperion Therapeutics in 2020 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 66 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
+17
Holders Change %
+10.3%
% of All Funds
3.74%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
40
Increased
66
Reduced
41
Closed
23
Calls
$47.6M
Puts
$35.5M
Net Calls
+$12.1M
Net Calls Change
+$16.5M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$89.7M |
| 2 |
Millennium Management
New York
|
$27.2M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
$28.7M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
$63.9M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
$272M |
